DEFLAZACORT VERSUS OTHER GLUCOCORTICOIDS: A COMPARISON

Steroids form an important component of dermatological therapy and are used since very long time for different conditions in different forms. Though very few molecules are used since very long time, the side effect associated with this group of drugs are almost always there. Recently a new molecule...

Descripción completa

Detalles Bibliográficos
Autores principales: Nayak, Surajit, Acharjya, Basanti
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2008
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763756/
https://www.ncbi.nlm.nih.gov/pubmed/19882026
http://dx.doi.org/10.4103/0019-5154.44786
_version_ 1782173035852201984
author Nayak, Surajit
Acharjya, Basanti
author_facet Nayak, Surajit
Acharjya, Basanti
author_sort Nayak, Surajit
collection PubMed
description Steroids form an important component of dermatological therapy and are used since very long time for different conditions in different forms. Though very few molecules are used since very long time, the side effect associated with this group of drugs are almost always there. Recently a new molecule deflazacort has been introduced into Indian market, is a glucocorticoid and a derivative of old molecule prednisolone. Though claimed to be having less side effect, very few studies have been done in Indian prospective. This review will highlight the very basics of this drug and its advantages and disadvantages.
format Text
id pubmed-2763756
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-27637562009-10-29 DEFLAZACORT VERSUS OTHER GLUCOCORTICOIDS: A COMPARISON Nayak, Surajit Acharjya, Basanti Indian J Dermatol Review Article Steroids form an important component of dermatological therapy and are used since very long time for different conditions in different forms. Though very few molecules are used since very long time, the side effect associated with this group of drugs are almost always there. Recently a new molecule deflazacort has been introduced into Indian market, is a glucocorticoid and a derivative of old molecule prednisolone. Though claimed to be having less side effect, very few studies have been done in Indian prospective. This review will highlight the very basics of this drug and its advantages and disadvantages. Medknow Publications 2008 /pmc/articles/PMC2763756/ /pubmed/19882026 http://dx.doi.org/10.4103/0019-5154.44786 Text en © Indian Journal of Dermatology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Nayak, Surajit
Acharjya, Basanti
DEFLAZACORT VERSUS OTHER GLUCOCORTICOIDS: A COMPARISON
title DEFLAZACORT VERSUS OTHER GLUCOCORTICOIDS: A COMPARISON
title_full DEFLAZACORT VERSUS OTHER GLUCOCORTICOIDS: A COMPARISON
title_fullStr DEFLAZACORT VERSUS OTHER GLUCOCORTICOIDS: A COMPARISON
title_full_unstemmed DEFLAZACORT VERSUS OTHER GLUCOCORTICOIDS: A COMPARISON
title_short DEFLAZACORT VERSUS OTHER GLUCOCORTICOIDS: A COMPARISON
title_sort deflazacort versus other glucocorticoids: a comparison
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763756/
https://www.ncbi.nlm.nih.gov/pubmed/19882026
http://dx.doi.org/10.4103/0019-5154.44786
work_keys_str_mv AT nayaksurajit deflazacortversusotherglucocorticoidsacomparison
AT acharjyabasanti deflazacortversusotherglucocorticoidsacomparison

Ejemplares similares